BR0014312A - Combinação de loteprednol e anti-histaminas - Google Patents
Combinação de loteprednol e anti-histaminasInfo
- Publication number
- BR0014312A BR0014312A BR0014312-0A BR0014312A BR0014312A BR 0014312 A BR0014312 A BR 0014312A BR 0014312 A BR0014312 A BR 0014312A BR 0014312 A BR0014312 A BR 0014312A
- Authority
- BR
- Brazil
- Prior art keywords
- loteprednol
- combination
- antihistamines
- antihistamins
- rhinoconjunctivitis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMBINAçãO DE LOTEPREDNOL E ANTIHISTAMINAS". A presente invenção refere-se a uma nova combinação de um esteróide mole, em particular loteprednol, e de pelo menos uma antihistamina, tal como, por exemplo, azelastina e/ou levocabastina, para administração simultânea, seq³encial ou separada no tratamento local de alergias e distúrbios das vias áreas, por exemplo de rinite alérgica (rinoconjuntivite).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19947234A DE19947234A1 (de) | 1999-09-30 | 1999-09-30 | Neue Kombination von Loteprednol und Antihistaminika |
| PCT/EP2000/009391 WO2001022955A2 (de) | 1999-09-30 | 2000-09-26 | Neue kombination von loteprednol und antihistaminika |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR0014312A true BR0014312A (pt) | 2002-05-21 |
| BR0014312B1 BR0014312B1 (pt) | 2012-09-04 |
Family
ID=7924100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0014312-0A BR0014312B1 (pt) | 1999-09-30 | 2000-09-26 | composição farmacêutica contendo uma combinação farmacêutica compreendendo loteprednol e azelastina, medicamento e seu processo de produção, e uso da referida combinação. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7022687B1 (pt) |
| EP (1) | EP1216046B1 (pt) |
| JP (2) | JP5524438B2 (pt) |
| AR (1) | AR025923A1 (pt) |
| AT (1) | ATE241988T1 (pt) |
| AU (1) | AU7907300A (pt) |
| BR (1) | BR0014312B1 (pt) |
| CA (1) | CA2387398C (pt) |
| CZ (1) | CZ295090B6 (pt) |
| DE (2) | DE19947234A1 (pt) |
| DK (1) | DK1216046T3 (pt) |
| EE (1) | EE04997B1 (pt) |
| ES (1) | ES2199868T3 (pt) |
| HU (1) | HU229606B1 (pt) |
| MX (1) | MXPA02003174A (pt) |
| PL (1) | PL196843B1 (pt) |
| PT (1) | PT1216046E (pt) |
| TW (1) | TWI224968B (pt) |
| WO (1) | WO2001022955A2 (pt) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050044550A (ko) * | 2001-12-05 | 2005-05-12 | 알콘, 인코퍼레이티드 | 비염 치료를 위한 η1 길항제 및 안전한 스테로이드제의용도 |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
| UA82323C2 (uk) * | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань |
| CA2495830C (en) * | 2002-08-30 | 2012-08-21 | Altana Pharma Ag | The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| JP2006508138A (ja) * | 2002-11-12 | 2006-03-09 | アルコン，インコーポレイテッド | アレルギー性鼻炎を処置するための抗アレルギー剤およびステロイドの使用 |
| US7879833B2 (en) | 2002-12-12 | 2011-02-01 | Nycomed Gmbh | Combination medicament |
| PT1670482E (pt) | 2003-09-16 | 2014-03-12 | Takeda Gmbh | Utilização de ciclesonida para o tratamento de doenças respiratórias |
| US20060263350A1 (en) * | 2003-09-26 | 2006-11-23 | Fairfield Clinical Trials Llc | Combination antihistamine medication |
| ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
| WO2005094836A2 (en) * | 2004-03-25 | 2005-10-13 | Bausch & Lomb Incorporated | Use of loteprednol etabonate for the treatment of dry eye |
| JP5607291B2 (ja) | 2004-11-24 | 2014-10-15 | メダ ファーマシューティカルズ インコーポレイテッド | アゼラスチンを含む組成物およびその使用方法 |
| US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| WO2012094283A2 (en) | 2011-01-04 | 2012-07-12 | Ista Pharmaceuticals, Inc. | Bepotastine compositions |
| JP2015518006A (ja) * | 2012-05-25 | 2015-06-25 | エクスクリア インコーポレイテッド | キシリトール系の抗粘膜組成物及び関連する方法並びに組成物 |
| US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
| US11938139B2 (en) | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
| US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
| US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
| US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
| US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
| US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
| US10898493B2 (en) | 2019-04-12 | 2021-01-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease |
| WO2021255622A1 (en) * | 2020-06-15 | 2021-12-23 | Alkem Laboratories Limited | Combination of alcaftadine and a corticosteroid |
| US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996335A (en) | 1980-07-10 | 1991-02-26 | Nicholas S. Bodor | Soft steroids having anti-inflammatory activity |
| US4710495A (en) | 1980-07-10 | 1987-12-01 | Otsuka Pharmaceutical Co., Ltd. | Soft steroids having anti-inflammatory activity |
| EP0709099A3 (en) | 1994-09-28 | 1996-07-24 | Senju Pharma Co | Aqueous suspension for nasal administration containing cyclodextrin |
| WO1997001337A1 (en) | 1995-06-29 | 1997-01-16 | Mcneil-Ppc, Inc. | The combination of topical nasal antihistamines and topical nasal steroids |
| AU3153797A (en) * | 1996-06-04 | 1998-01-05 | Procter & Gamble Company, The | A nasal spray containing an intranasal steroid and an antihistamine |
| JP4453987B2 (ja) * | 1997-01-16 | 2010-04-21 | 千寿製薬株式会社 | 点鼻用水性懸濁液 |
-
1999
- 1999-09-30 DE DE19947234A patent/DE19947234A1/de not_active Withdrawn
-
2000
- 2000-09-26 CA CA002387398A patent/CA2387398C/en not_active Expired - Fee Related
- 2000-09-26 EP EP00969303A patent/EP1216046B1/de not_active Expired - Lifetime
- 2000-09-26 WO PCT/EP2000/009391 patent/WO2001022955A2/de not_active Ceased
- 2000-09-26 HU HU0202862A patent/HU229606B1/hu not_active IP Right Cessation
- 2000-09-26 DE DE50002478T patent/DE50002478D1/de not_active Expired - Lifetime
- 2000-09-26 TW TW089119859A patent/TWI224968B/zh not_active IP Right Cessation
- 2000-09-26 CZ CZ20021014A patent/CZ295090B6/cs not_active IP Right Cessation
- 2000-09-26 ES ES00969303T patent/ES2199868T3/es not_active Expired - Lifetime
- 2000-09-26 US US10/089,436 patent/US7022687B1/en not_active Expired - Fee Related
- 2000-09-26 JP JP2001526167A patent/JP5524438B2/ja not_active Expired - Fee Related
- 2000-09-26 AT AT00969303T patent/ATE241988T1/de active
- 2000-09-26 AU AU79073/00A patent/AU7907300A/en not_active Abandoned
- 2000-09-26 PT PT00969303T patent/PT1216046E/pt unknown
- 2000-09-26 PL PL353486A patent/PL196843B1/pl unknown
- 2000-09-26 MX MXPA02003174A patent/MXPA02003174A/es active IP Right Grant
- 2000-09-26 BR BRPI0014312-0A patent/BR0014312B1/pt not_active IP Right Cessation
- 2000-09-26 DK DK00969303T patent/DK1216046T3/da active
- 2000-09-26 EE EEP200200146A patent/EE04997B1/xx not_active IP Right Cessation
- 2000-09-29 AR ARP000105166A patent/AR025923A1/es not_active Application Discontinuation
-
2011
- 2011-09-12 JP JP2011198367A patent/JP2012001558A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20021014A3 (cs) | 2002-06-12 |
| AR025923A1 (es) | 2002-12-18 |
| BR0014312B1 (pt) | 2012-09-04 |
| CA2387398A1 (en) | 2002-03-28 |
| PL353486A1 (en) | 2003-11-17 |
| DE19947234A1 (de) | 2001-04-05 |
| JP2012001558A (ja) | 2012-01-05 |
| CZ295090B6 (cs) | 2005-05-18 |
| EP1216046A2 (de) | 2002-06-26 |
| TWI224968B (en) | 2004-12-11 |
| HU229606B1 (en) | 2014-02-28 |
| DK1216046T3 (da) | 2003-09-29 |
| ATE241988T1 (de) | 2003-06-15 |
| JP5524438B2 (ja) | 2014-06-18 |
| CA2387398C (en) | 2009-05-12 |
| MXPA02003174A (es) | 2003-08-20 |
| JP2003510275A (ja) | 2003-03-18 |
| EE200200146A (et) | 2003-04-15 |
| DE50002478D1 (de) | 2003-07-10 |
| PT1216046E (pt) | 2003-10-31 |
| AU7907300A (en) | 2001-04-30 |
| HUP0202862A3 (en) | 2003-10-28 |
| HUP0202862A2 (hu) | 2003-01-28 |
| WO2001022955A2 (de) | 2001-04-05 |
| US7022687B1 (en) | 2006-04-04 |
| ES2199868T3 (es) | 2004-03-01 |
| WO2001022955A3 (de) | 2001-05-17 |
| EE04997B1 (et) | 2008-04-15 |
| EP1216046B1 (de) | 2003-06-04 |
| PL196843B1 (pl) | 2008-02-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0014312A (pt) | Combinação de loteprednol e anti-histaminas | |
| HUP0303917A2 (hu) | Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére | |
| BR0014912A (pt) | Tratamento de distúrbios do sono usando desloratadina | |
| WO2004019884A3 (en) | Agents and methods for enhancing bone formation | |
| ATE311148T1 (de) | Chirurgische vorrichtungen | |
| IL151371A0 (en) | Modified porcine factor viii and pharmaceutical compositions containing the same | |
| BR0211062A (pt) | Combinações para o tratamento de distúrbios inflamatórios | |
| NO20003546L (no) | Anvendelse av progestin og en farmasøytisk sammensetning samt et kit inneholdende disse | |
| NO20033446D0 (no) | Medikament for behandling av osteonekrose og for pleie av personer med risiko for å utvikle osteonekrose | |
| MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
| BRPI0111591B8 (pt) | composto, composição farmacêutica, e, usos de um composto | |
| WO2001041753A3 (en) | Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds | |
| SE0104423D0 (sv) | Pregnane steroids and their use in the treatment of CNS disorders | |
| BR0114665A (pt) | Uso de antiprogestinas para a profilaxia e tratamento de doenças dependentes de hormÈnio | |
| BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
| GB0020504D0 (en) | Therapeutic method | |
| NO20024735L (no) | Anvendelse av fulvestrant for behandling av resistent brystkreft | |
| BR0308584A (pt) | Composição farmacêutica androgênica e método para tratamento de depressão | |
| BR0107960A (pt) | Tratamento de condições alérgicas e inflamatórias | |
| BR0206819A (pt) | Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| UA86802C2 (ru) | Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота | |
| NO990450L (no) | Behandling av sinnslidelser | |
| BR0213162A (pt) | Métodos para prevenção e tratamento da perda óssea com compostos esteróides | |
| BR0014374A (pt) | Combinação de loteprednol e agonistas do adrenorreceptor beta dois |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: VIATRIS GMBH AND CO. KG (DE) Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020050037237/RJ DE 17/05/2005. |
|
| B25D | Requested change of name of applicant approved |
Owner name: MEDA PHARMA GMBH AND CO. KG (DE) Free format text: ALTERADO DE: VIATRIS GMBH AND CO. KG |
|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/09/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 18A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2481 DE 24-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |